Our aim was to assess the pathophysiologic contributions to NICO of anticardiolipin antibodies (aCLA), thrombophilia (increased tendency to intravascular thrombi), and hypofibrinolysis (reduced ...

Both agencies are cautioning against a once-daily administration "in patients with thrombophilia", where "a twice daily administration of nadroparin should be considered", instead. It follows ...